Prime Medicine, Inc. - Common Stock — Bilan (NASDAQ:PRME) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes

Trimestriel Annuel

Total de l'actif 360.31 M193.85 M297.51 M342.73 M Total du passif 44.04 M60.78 M144.36 M221.87 M Total des capitaux propres 316.27 M133.07 M153.15 M120.87 M Total du passif et des capitaux propres 360.31 M193.85 M297.51 M342.73 M Dette totale ———— Dette nette ————

Prime Medicine, Inc. - Common Stock

Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.

Nouvelles

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates

Prime Drink Group annonce un placement privé pouvant atteindre 4 millions C$

Prime Medicine, Inc. (PRME) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Citizens réitère sa note sur l’action Prime Medicine concernant PM359

Citizens reiterates Prime Medicine stock rating on PM359 pathway

Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates

Prime Drink Group finalise la première clôture de son placement privé

Prime Drink Group completes first closing of private placement

Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond